Despite having thicker tumors, patients with RQCD1 mutant melanomas were no more likely to present with nodal disease compared to the rest of the cohort (p = 0.3), with only 3 patients (10%) presenting with stage III disease at diagnosis (Table 4). This evidence concerns the gene CNOT9 and melanoma.